Mary K Grabowski1, Ronald H Gray2, David Serwadda3, Godfrey Kigozi4, Patti E Gravitt5, Fred Nalugoda4, Steven J Reynolds6, Maria J Wawer2, Stephen Watya7, Thomas C Quinn8, Aaron A R Tobian9. 1. Department of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA. 2. Department of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA Rakai Health Sciences Program, Entebbe, Uganda. 3. Rakai Health Sciences Program, Entebbe, Uganda School of Public Health, Makerere University, Kampala, Uganda. 4. Rakai Health Sciences Program, Entebbe, Uganda. 5. Department of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA Perdana University Graduate School of Medicine, Serdang, Malaysia. 6. Department of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA Rakai Health Sciences Program, Entebbe, Uganda Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA. 7. Department of Urology, Makerere University, Kampala, Uganda. 8. Rakai Health Sciences Program, Entebbe, Uganda Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA. 9. Rakai Health Sciences Program, Entebbe, Uganda Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Abstract
OBJECTIVES: High-risk human papillomavirus (HR-HPV) viral load is associated with HR-HPV transmission and HR-HPV persistence in women. It is unknown whether HR-HPV viral load is associated with persistence in HIV-negative or HIV-positive men. METHODS: HR-HPV viral load and persistence were evaluated among 703 HIV-negative and 233 HIV-positive heterosexual men who participated in a male circumcision trial in Rakai, Uganda. Penile swabs were tested at baseline and 6, 12 and 24 months for HR-HPV using the Roche HPV Linear Array, which provides a semiquantitative measure of HPV shedding by hybridisation band intensity (graded: 1-4). Prevalence risk ratios (PRR) were used to estimate the association between HR-HPV viral load and persistent detection of HR-HPV. RESULTS: HR-HPV genotypes with high viral load (grade:3-4) at baseline were more likely to persist than HR-HPV genotypes with low viral load (grade: 1-2) among HIV-negative men (month 6: adjPRR=1.83, 95% CI 1.32 to 2.52; month 12: adjPRR=2.01, 95% CI 1.42 to 3.11), and HIV-positive men (month 6: adjPRR=1.33, 95% CI 1.06 to 1.67; month 12: adjPRR=1.73, 95% CI 1.18 to 2.54). Long-term persistence of HR-HPV was more frequent among HIV-positive men compared with HIV-negative men (month 24: adjPRR=2.27, 95% CI 1.47 to 3.51). Persistence of newly detected HR-HPV at the 6-month and 12-month visits with high viral load were also more likely to persist to 24 months than HR-HPV with low viral load among HIV-negative men (adjPRR=1.67, 95% CI 0.88 to 3.16). CONCLUSIONS: HR-HPV genotypes with high viral load are more likely to persist among HIV-negative and HIV-positive men, though persistence was more common among HIV-positive men overall. The results may explain the association between high HR-HPV viral load and HR-HPV transmission. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
OBJECTIVES: High-risk human papillomavirus (HR-HPV) viral load is associated with HR-HPV transmission and HR-HPV persistence in women. It is unknown whether HR-HPV viral load is associated with persistence in HIV-negative or HIV-positive men. METHODS:HR-HPV viral load and persistence were evaluated among 703 HIV-negative and 233 HIV-positive heterosexual men who participated in a male circumcision trial in Rakai, Uganda. Penile swabs were tested at baseline and 6, 12 and 24 months for HR-HPV using the Roche HPV Linear Array, which provides a semiquantitative measure of HPV shedding by hybridisation band intensity (graded: 1-4). Prevalence risk ratios (PRR) were used to estimate the association between HR-HPV viral load and persistent detection of HR-HPV. RESULTS: HR-HPV genotypes with high viral load (grade:3-4) at baseline were more likely to persist than HR-HPV genotypes with low viral load (grade: 1-2) among HIV-negative men (month 6: adjPRR=1.83, 95% CI 1.32 to 2.52; month 12: adjPRR=2.01, 95% CI 1.42 to 3.11), and HIV-positive men (month 6: adjPRR=1.33, 95% CI 1.06 to 1.67; month 12: adjPRR=1.73, 95% CI 1.18 to 2.54). Long-term persistence of HR-HPV was more frequent among HIV-positive men compared with HIV-negative men (month 24: adjPRR=2.27, 95% CI 1.47 to 3.51). Persistence of newly detected HR-HPV at the 6-month and 12-month visits with high viral load were also more likely to persist to 24 months than HR-HPV with low viral load among HIV-negative men (adjPRR=1.67, 95% CI 0.88 to 3.16). CONCLUSIONS: HR-HPV genotypes with high viral load are more likely to persist among HIV-negative and HIV-positive men, though persistence was more common among HIV-positive men overall. The results may explain the association between high HR-HPV viral load and HR-HPV transmission. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Howard D Strickler; Robert D Burk; Melissa Fazzari; Kathryn Anastos; Howard Minkoff; L Stewart Massad; Charles Hall; Melanie Bacon; Alexandra M Levine; D Heather Watts; Michael J Silverberg; Xiaonan Xue; Nicolas F Schlecht; Sandra Melnick; Joel M Palefsky Journal: J Natl Cancer Inst Date: 2005-04-20 Impact factor: 13.506
Authors: Maaike C G Bleeker; Cornelis J A Hogewoning; Feja J Voorhorst; Adriaan J C van den Brule; Johannes Berkhof; Albertus T Hesselink; Marjolein Lettink; Theo M Starink; Tom J Stoof; Peter J F Snijders; Chris J L M Meijer Journal: Int J Cancer Date: 2005-01-01 Impact factor: 7.396
Authors: Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer Journal: N Engl J Med Date: 2003-02-06 Impact factor: 91.245
Authors: Patti E Gravitt; Anne F Rositch; Michelle I Silver; Morgan A Marks; Kathryn Chang; Anne E Burke; Raphael P Viscidi Journal: J Infect Dis Date: 2012-12-12 Impact factor: 5.226
Authors: Aaron A R Tobian; Mary K Grabowski; Godfrey Kigozi; Andrew D Redd; Kevin P Eaton; David Serwadda; Toby C Cornish; Fred Nalugoda; Stephen Watya; Denis Buwembo; James Nkale; Maria J Wawer; Thomas C Quinn; Ronald H Gray Journal: J Infect Dis Date: 2013-01-23 Impact factor: 5.226
Authors: M C G Bleeker; J Berkhof; C J A Hogewoning; F J Voorhorst; A J C van den Brule; T M Starink; P J F Snijders; C J L M Meijer Journal: Br J Cancer Date: 2005-04-25 Impact factor: 7.640
Authors: Mary K Grabowski; Xiangrong Kong; Ronald H Gray; David Serwadda; Godfrey Kigozi; Patti E Gravitt; Fred Nalugoda; Steven J Reynolds; Maria J Wawer; Andrew D Redd; Stephen Watya; Thomas C Quinn; Aaron A R Tobian Journal: J Infect Dis Date: 2015-11-23 Impact factor: 5.226
Authors: Margaret Rosario; Fei Li; David Wypij; Andrea L Roberts; Heather L Corliss; Brittany M Charlton; A Lindsay Frazier; S Bryn Austin Journal: Am J Public Health Date: 2016-01-21 Impact factor: 9.308
Authors: Virginia Senkomago; Danielle M Backes; Michael G Hudgens; Charles Poole; Steven R Meshnick; Kawango Agot; Stephen Moses; Peter Jf Snijders; Chris Jlm Meijer; Albertus T Hesselink; Nicolas F Schlecht; Robert C Bailey; Jennifer S Smith Journal: Sex Transm Dis Date: 2016-09 Impact factor: 2.830
Authors: A L Wirtz; C E Zelaya; A Peryshkina; I McGowan; R D Cranston; C Latkin; N Galai; V Mogilniy; P Dzhigun; I Kostetskaya; C Beyrer Journal: Euro Surveill Date: 2015-04-16
Authors: Jeanne A M C Dirks; Petra F G Wolffs; Nicole H T M Dukers-Muijrers; Antoinette A T P Brink; Arjen G C L Speksnijder; Christian J P A Hoebe Journal: PLoS One Date: 2015-03-31 Impact factor: 3.240
Authors: Katharine J Looker; Minttu M Rönn; Patrick M Brock; Marc Brisson; Melanie Drolet; Philippe Mayaud; Marie-Claude Boily Journal: J Int AIDS Soc Date: 2018-06 Impact factor: 5.396
Authors: Evy Yunihastuti; Nipat Teeratakulpisarn; Wifanto Saditya Jeo; Hanny Nilasari; Lisnawati Rachmadi; I Ketut Agus Somia; Made Dewi Dian Sukmawati; Komang Agus Trisna Amijaya; Ilias A Yee; Nany Hairunisa; Piranun Hongchookiat; Deondara Trachunthong; Tippawan Pankam; Siriporn Nonenoy; Reshmie Ramautarsing; Iskandar Azwa; Tuti P Merati; Praphan Phanuphak; Nittaya Phanuphak; Joel M Palefsky Journal: AIDS Date: 2020-11-01 Impact factor: 4.632